MCF Advisors’s AYTU BioPharma AYTU Stock Holding History

MCF Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-89	Closed	-$227K	–	437
2018 Q1	$227K	Buy	+89	New	+$612K	0.04%	107

Other funds holding AYTU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

MCF Advisors's AYTU Position: Q2 2018 in Review

MCF Advisors sold out of AYTU BioPharma (AYTU) in Q2 2018, closing a stake of 89 shares — an estimated $227K sold.

MCF Advisors first reported a position in AYTU in Q1 2018 and held it in 1 quarter. The position peaked at $227K in Q1 2018. 14 funds tracked by Wall St. Rank hold AYTU as of Q2 2018.

MCF Advisors reported no remaining AYTU BioPharma position as of Q2 2018 after selling out during the quarter.
MCF Advisors sold 89 AYTU BioPharma shares in Q2 2018, an estimated $227K.
MCF Advisors first reported a position in AYTU BioPharma in Q1 2018 and held it in 1 quarter.
MCF Advisors's AYTU BioPharma position peaked at $227K in Q1 2018.
14 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2018.

Based on MCF Advisors's 13F filing for Q2 2018, filed 20 Jul 2018.